PUTRAJAYA — The Health Ministry (MoH) will continue prioritising education and awareness in enforcing the Price Control and Anti-Profiteering (Medicine Price Labelling) Order 2025, despite an ongoing judicial review application challenging the regulation.
Health Minister Datuk Seri Dr Dzulkefly Ahmad said while the ministry respects the ongoing legal process, it remains committed to implementing the order through educational enforcement approach.
“We will continue with this approach to avoid enforcement gaps while the court process is ongoing,” he told reporters after officiating the 2025 National Health Technology Assessment Conference and the 30th anniversary of the Malaysian Health Technology Assessment Section (MaHTAS) here today.
The regulation, which took effect on May 1, requires all private clinics and community pharmacies to clearly display medicine prices — either on shelves, in catalogues, or through written price lists — under the 2025 price labelling order.
Dr Dzulkefly was responding to reports that the Malaysian Medical Association (MMA) and seven other organisations have applied for leave to initiate a judicial review against the directive.
Among the applicants are the Sabah Private Practitioners Association (APPS), the Malaysian Association for the Advancement of Functional and Interdisciplinary Medicine (MAAFIM), the Malaysian Muslim Doctors Association (PERDIM), and the Federation of Private Medical Practitioners’ Associations Malaysia (FPMPAM).
On May 4, Dr Dzulkefly had clarified that no fines or compounds would be issued during the first three months of enforcement, as the ministry’s initial focus was on educating stakeholders.
As of now, neither MOH nor the Domestic Trade and Cost of Living Ministry (KPDN) has announced any extension to the grace period, which ends tomorrow. — July 30, 2025
The post MOH maintains educational approach on medicine price labelling amid legal challenge appeared first on Scoop.
